Solventum (SOLV): analysis and statistics
Return, volatility, Sharpe ratio and risk for Solventum, a component of the S&P 500 in the Health Care. Data as of 2026-10-29.
| Last close price | $81.85 |
| Sector (GICS) | Health Care |
| Annualized return (0.3 yr) | +12.14% |
| Total return over period | +3.28% |
| Annualized volatility | 27.70% |
| Period volatility | 14.70% |
| Period T-bill | 1.11% |
| Sharpe ratio | 0.15 |
| Sortino ratio | 0.23 |
| Max drawdown | -11.46% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.70% |
| Correlation with the S&P 500 | 0.02 |
| Period range | $77.24 – $92.44 |
| Trading days analyzed | 71 |
Over the last 0.3 years, Solventum (SOLV) has posted an annualized return of +12.14% with annual volatility of 27.70%, a Sharpe ratio of 0.15. Its worst stretch (max drawdown from a peak) was -11.46%. Its correlation with the S&P 500 is 0.02, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how SOLV would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with SOLV →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Solventum (SOLV) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio